is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat
DNP-PEG4-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs
1863(1):31-38
3-d]pyrimidin-5-yl}-2-methylpent-4-yn-2-ol
Studies indicate that ATP production is shifted towards glucose oxidation by Ranolazine
(-)-Corey lactone diol-heptyldioxolane-d15 Catalog No.:M26740-C is a medication developed byProduct information CAS Number: 1217783 38 4 Molecular Weight: 355. 55 Formula: C19H32O5 Chemical Name: (3aR,4R,5R,6aS) 4 (2 {2 [(1,1,2,2,3,3,4,4,5,5,6,6,7,7,7 H)heptyl] 1,3 dioxolan 2 yl}ethyl) 5 hydroxy hexahydro 2H cyclopenta[b]furan 2 one Smiles: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C1(CC[C@H]2[C@H](O)C[C@@H]3OC(=O)C[C@H]23)OCCO1 InChiKey: ATVQZEZXTPHWTH KCEJTPJJSA N InChi: InChI=1S